ESR1 and breast carcinoma: In the present study, a routine immunohistochemical method was used to analyze the expression of ER, PR, CK 5/6, HER2 and Ki-67, as well as a novel hypothetical marker, NUCKS1, in 90 cases of invasive non-specific breast carcinoma.